Neuromodulators, such as prabotulinumtoxinA (Jeuveau), are injectables commonly used to temporarily improve the appearance of moderate to severe frown lines between the eyebrows (glabellar lines). Typically, initial visible improvements can be observed within a few days, with full effects generally appearing within two weeks. The duration of these effects varies from patient to patient, but commonly lasts three to four months, after which further treatment may be desired.
Understanding the timeframe for visible improvement following treatment is crucial for managing patient expectations. This knowledge promotes realistic goals and reduces potential anxiety related to the treatment process. Clear communication regarding the onset and duration of effects contributes significantly to patient satisfaction. Additionally, understanding these timelines allows clinicians to schedule follow-up appointments appropriately and tailor treatment plans to individual patient needs.